Conservative treatment for cataract: state-of-the-art

<p> <b>S.Yu. Petrov, I.V.&nbsp;Kozlova, R.P.&nbsp;Poleva</b><br> </p> <p> <b>Scientific Research Institute of Eye Diseases, Moscow, Russian Federation</b> </p> <p> <br> </p> <p> <i>Cataract is one of the...

Full description

Saved in:
Bibliographic Details
Main Authors: S.Yu. Petrov, I.V. Kozlova, R.P. Poleva
Format: Article
Language:Russian
Published: Prime-Media 2019-11-01
Series:РМЖ "Клиническая офтальмология"
Online Access:http://clinopht.com/upload/iblock/dbb/dbb23ff80d43a0c48e15fdd0ae5be522.pdf
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1841526902648471552
author S.Yu. Petrov
I.V. Kozlova
R.P. Poleva
author_facet S.Yu. Petrov
I.V. Kozlova
R.P. Poleva
author_sort S.Yu. Petrov
collection DOAJ
description <p> <b>S.Yu. Petrov, I.V.&nbsp;Kozlova, R.P.&nbsp;Poleva</b><br> </p> <p> <b>Scientific Research Institute of Eye Diseases, Moscow, Russian Federation</b> </p> <p> <br> </p> <p> <i>Cataract is one of the leading causes of blindness worldwide and an important medical social issue in many countries. Cataract extraction and implantation of intraocular lens is the only effective treatment. However, cataract surgery is still not available for many patients for several reasons even despite the progress in phaco surgery in the last decade as well as WHO project on eye care accessibility improvement. Among these reasons are the high cost of the surgery, inaccessibility of highly specialized health care, somatic comorbidities, and psychological unwillingness. Cataract significantly reduces working capacity and the quality of life. Despite high occurrence and scientific interest, cataract pathogensis is still an enigma. Pharmacotherapy to inhibit cataractogenesis is a promising but unexplored treatment modality. This paper addresses published data for different years on the studies on this issue. The basis for pharmacotherapy is the effect on metab olic processes in the lens to prevent oxidative stress and lens opacities. Oftan<sup>®</sup> Catachrom containts adenosine, nicotinamide, and cytochrome C.&nbsp;Currently, this agent is a well-studied medication used when cataract surgery cannot be performed. There is a number of clinical trias on the effect of Oftan<sup>®</sup> Catachrome on visual acuity and lens using various regimens of long-term instillations.</i> </p> <p> <i><b>Keywords</b>: cataract, lens, opacity, prevention, phacoemulsification, Oftan Catachrom.</i> </p> <p> <i><b>For citation: </b>Petrov S.Yu., Kozlova I.V., Poleva R.P. Conservative treatment for cataract: state-of-the-art. Russian Journal of Clinical Ophthalmology. 2019;19(4):206–210.</i> </p> <i><br> </i><br>
format Article
id doaj-art-a96c1fa3f01b4a52b819585f57cda5c8
institution Kabale University
issn 2311-7729
2619-1571
language Russian
publishDate 2019-11-01
publisher Prime-Media
record_format Article
series РМЖ "Клиническая офтальмология"
spelling doaj-art-a96c1fa3f01b4a52b819585f57cda5c82025-01-16T09:39:37ZrusPrime-MediaРМЖ "Клиническая офтальмология"2311-77292619-15712019-11-0119430766Conservative treatment for cataract: state-of-the-artS.Yu. Petrov0I.V. Kozlova1R.P. Poleva2Russian Journal of Clinical Ophthalmology, Publisher of «Medicina-Inform» Address for correspondence: Russia, 105064, Moscow, P.O. Box 399Russian Journal of Clinical Ophthalmology, Publisher of «Medicina-Inform» Address for correspondence: Russia, 105064, Moscow, P.O. Box 399Russian Journal of Clinical Ophthalmology, Publisher of «Medicina-Inform» Address for correspondence: Russia, 105064, Moscow, P.O. Box 399<p> <b>S.Yu. Petrov, I.V.&nbsp;Kozlova, R.P.&nbsp;Poleva</b><br> </p> <p> <b>Scientific Research Institute of Eye Diseases, Moscow, Russian Federation</b> </p> <p> <br> </p> <p> <i>Cataract is one of the leading causes of blindness worldwide and an important medical social issue in many countries. Cataract extraction and implantation of intraocular lens is the only effective treatment. However, cataract surgery is still not available for many patients for several reasons even despite the progress in phaco surgery in the last decade as well as WHO project on eye care accessibility improvement. Among these reasons are the high cost of the surgery, inaccessibility of highly specialized health care, somatic comorbidities, and psychological unwillingness. Cataract significantly reduces working capacity and the quality of life. Despite high occurrence and scientific interest, cataract pathogensis is still an enigma. Pharmacotherapy to inhibit cataractogenesis is a promising but unexplored treatment modality. This paper addresses published data for different years on the studies on this issue. The basis for pharmacotherapy is the effect on metab olic processes in the lens to prevent oxidative stress and lens opacities. Oftan<sup>®</sup> Catachrom containts adenosine, nicotinamide, and cytochrome C.&nbsp;Currently, this agent is a well-studied medication used when cataract surgery cannot be performed. There is a number of clinical trias on the effect of Oftan<sup>®</sup> Catachrome on visual acuity and lens using various regimens of long-term instillations.</i> </p> <p> <i><b>Keywords</b>: cataract, lens, opacity, prevention, phacoemulsification, Oftan Catachrom.</i> </p> <p> <i><b>For citation: </b>Petrov S.Yu., Kozlova I.V., Poleva R.P. Conservative treatment for cataract: state-of-the-art. Russian Journal of Clinical Ophthalmology. 2019;19(4):206–210.</i> </p> <i><br> </i><br>http://clinopht.com/upload/iblock/dbb/dbb23ff80d43a0c48e15fdd0ae5be522.pdf
spellingShingle S.Yu. Petrov
I.V. Kozlova
R.P. Poleva
Conservative treatment for cataract: state-of-the-art
РМЖ "Клиническая офтальмология"
title Conservative treatment for cataract: state-of-the-art
title_full Conservative treatment for cataract: state-of-the-art
title_fullStr Conservative treatment for cataract: state-of-the-art
title_full_unstemmed Conservative treatment for cataract: state-of-the-art
title_short Conservative treatment for cataract: state-of-the-art
title_sort conservative treatment for cataract state of the art
url http://clinopht.com/upload/iblock/dbb/dbb23ff80d43a0c48e15fdd0ae5be522.pdf
work_keys_str_mv AT syupetrov conservativetreatmentforcataractstateoftheart
AT ivkozlova conservativetreatmentforcataractstateoftheart
AT rppoleva conservativetreatmentforcataractstateoftheart